文献速递肾移植

人内皮细胞II类人类白细胞抗原表达呈现高度个体间及亚类间异质性

Expression of Class II Human Leukocyte Antigens on Human Endothelial Cells Shows High Interindividual and Intersubclass Heterogeneity.
PubMed 文献 · J Am Soc Nephrol · 2023-02-09

研究利用39例人外周血单核细胞来源的内皮集落形成细胞系,通过流式细胞术和免疫荧光染色分析II类HLA表达,发现个体间及亚类间差异显著,HLA-DQ变异最大(阳性细胞0%–85%)。肾移植受者中HLA-DQ5错配与移植肾微血管损伤显著增加相关。

要点

  • 内皮细胞II类HLA表达存在显著个体间和亚类间异质性,HLA-DQ变异最大。
  • HLA-DQ5和-DQ6与较高表达水平相关,HLA-DQ7、-DQ8和-DQ9与较低表达相关。
  • 肾移植受者中HLA-DQ5错配与移植肾微血管损伤显著增加相关。

核心结论

  • 内皮细胞II类HLA表达具有高度个体间和亚类间异质性,挑战HLA抗原为单一遗传和翻译后实体的现有范式。

研究设计与样本

  • 研究从人外周血单核细胞生成内皮集落形成细胞系(n=39),采用流式细胞术和免疫荧光染色分析,并分析两个肾移植受者队列以关联HLA-DQ错配与移植肾微血管损伤程度。

主要发现

  • II类HLA抗原表达在个体间及亚类间呈现大幅变异,HLA-DQ抗原表达低且异质,阳性细胞范围0%至85%。
  • 同一患者内,内皮细胞集落与抗原提呈细胞间的表达一致。
  • HLA-DQ5和-DQ6与较高表达水平相关,HLA-DQ7、-DQ8和-DQ9与较低表达水平相关。
  • 肾移植受者中HLA-DQ5错配与移植肾微血管损伤显著增加相关。

临床怎么用

  • 作者认为,测量移植肾内皮II类HLA表达可能为评估移植及某些疾病中的同种免疫风险提供新范式。
  • 作者认为,理解和评估HLA抗原表达变异性可能在移植、自身免疫疾病和肿瘤学中具有临床监测和治疗应用。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: Donor-specific antibodies against class II HLA are a major cause of chronic kidney graft rejection. Nonetheless, some patients presenting with these antibodies remain in stable histological and clinical condition. This study describes the use of endothelial colony-forming cell lines to test the hypothesis of the heterogeneous expression of HLA molecules on endothelial cells in humans. Flow cytometry and immunofluorescence staining revealed substantial interindividual and interlocus variability, with HLA-DQ the most variable. Our data suggest that the expression of HLA class II is predicted by locus. The measurement of endothelial expression of HLA class II in the graft could present a novel paradigm in the evaluation of the alloimmune risk in transplantation and certain diseases. BACKGROUND: HLA antigens are important targets of alloantibodies and allospecific T cells involved in graft rejection. Compared with research into understanding alloantibody development, little is known about the variability in expression of their ligands on endothelial cells. We hypothesized individual variability in the expression of HLA molecules. METHODS: We generated endothelial colony forming cell lines from human peripheral blood mononuclear cells ( n =39). Flow cytometry and immunofluorescence staining were used to analyze the cells, and we assessed the relationship between HLA-DQ expression and genotype. Two cohorts of kidney transplant recipients were analyzed to correlate HLA-DQ mismatches with the extent of intragraft microvascular injury. RESULTS: Large variability was observed in the expression of HLA class II antigens, not only between individuals but also between subclasses. In particular, HLA-DQ antigens had a low and heterogeneous expression, ranging from 0% to 85% positive cells. On a within-patient basis, this expression was consistent between endothelial cell colonies and antigen-presenting cells. HLA-DQ5 and -DQ6 were associated with higher levels of expression, whereas HLA-DQ7, -DQ8, and -DQ9 with lower. HLA-DQ5 mismatches among kidney transplant recipients were associated with significant increase in graft microvascular. CONCLUSION: These data challenge the current paradigm that HLA antigens, in particular HLA class II, are a single genetic and post-translational entity. Understanding and assessing the variability in the expression of HLA antigens could have clinical monitoring and treatment applications in transplantation, autoimmune diseases, and oncology.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Béland S, Désy O, El Fekih R, et al. Expression of Class II Human Leukocyte Antigens on Human Endothelial Cells Shows High Interindividual and Intersubclass Heterogeneity. J Am Soc Nephrol. 2023. PMID: 36758118. doi:10.1681/ASN.0000000000000095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。